Intra-Cellular Therapies
ITCI
#1800
Rank
$9.06 B
Marketcap
$85.52
Share price
-2.41%
Change (1 day)
50.82%
Change (1 year)

Market capitalization of Intra-Cellular Therapies (ITCI)

Market cap: $9.06 Billion USD

As of November 2024 Intra-Cellular Therapies has a market cap of $9.06 Billion USD. This makes Intra-Cellular Therapies the world's 1800th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Intra-Cellular Therapies from 2013 to 2024

End of year Market Cap

Year Marketcap Change
2024$9.06 B31.53%
2023$6.89 B37.53%
2022$5.01 B17.54%
2021$4.26 B66.64%
2020$2.55 B34.35%
2019$1.90 B204.59%
2018$0.62 B-20.88%
2017$0.79 B21.04%
2016$0.65 B-71.87%
2015$2.32 B345.85%
2014$0.52 B17.48%
2013$0.44 B

End of Day market cap according to different sources

On Nov 14th, 2024 the market cap of Intra-Cellular Therapies was reported to be:

$9.29 Billion USD
by Nasdaq info icon info icon
$9.29 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
$91.22 M-98.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$22.39 M-99.75%๐Ÿ‡บ๐Ÿ‡ธ USA
$1.58 B-82.47%๐Ÿ‡บ๐Ÿ‡ธ USA